Physician profile
Deepika Singh
NPI 1275844946
$2,410.46
in general payments reported to CMS, 2019-2025
18 companies · $104 in 2025
The $104 reported for 2025 was less than what a typical Pediatric Rheumatology provider received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $925 · 2020: $246 · 2021: $141 · 2022: $228 · 2023: $158 · 2024: $609 · 2025: $104.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $871.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $870.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $867.11 | 2019-2024 | Enbrel, Otezla |
| Novartis Pharmaceuticals Corporation | $245.98 | 2019-2025 | |
| Pfizer INC. | $226.36 | 2019-2025 | |
| Genentech USA, INC. | $170.96 | 2019-2020 | |
| Glaxosmithkline, LLC. | $167.02 | 2023-2025 | Benlysta |
| Abbvie INC. | $152.36 | 2020-2025 | |
| E.R. Squibb & Sons, L.L.C. | $125.69 | 2019-2024 | Orencia |
| Medexus Pharma, INC. | $108.49 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $73.21 | 2023-2024 | Saphnelo |
| Mallinckrodt Enterprises LLC | $66.85 | 2019 | |
| Allergan, INC. | $35.79 | 2020 | |
| Organon LLC | $31.69 | 2025 | Hadlima, Renflexis |
| Azurity Pharmaceuticals, INC. | $28.22 | 2024 | Xatmep |
| Biocon Biologics INC | $28.07 | 2024 | Hulio |
| Alexion Pharmaceuticals, INC. | $24.61 | 2024 | Strensiq |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $22.77 | 2024 | Cyltezo |
| Csl Behring | $21.80 | 2019 | |
| Masimo Corporation | $13.48 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Deepika Singh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.